Mauro Angiolini

Title: Mauro Angiolini: Innovator in Heterocyclic Derivatives

Introduction

Mauro Angiolini is a notable inventor based in Varese, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of heterocyclic derivatives. His work focuses on therapeutic applications for various diseases, including cancer and neurodegenerative disorders.

Latest Patents

Mauro Angiolini holds a patent for "Heterocyclic derivatives modulating activity of certain protein kinases." This invention relates to novel heterocyclic derivatives characterized by a general formula (I). These compounds have therapeutic uses for diseases such as cancer, inflammation, pain, autoimmune diseases, and neurodegenerative diseases like Alzheimer's and Parkinson's disease. The compounds can be particularly beneficial for patients who do not respond to existing kinase inhibition therapies.

Career Highlights

Throughout his career, Mauro Angiolini has worked with several esteemed organizations. He has been associated with Eudendron S.r.l., where he contributed to innovative research and development. Additionally, he has collaborated with the Università Degli Studi Di Milano, further enhancing his expertise in the field.

Collaborations

Mauro Angiolini has worked alongside notable colleagues, including Fabio Zuccotto and Anna Bernardi. Their collaborative efforts have contributed to advancements in the understanding and application of heterocyclic compounds in medicine.

Conclusion

Mauro Angiolini's work in the field of heterocyclic derivatives showcases his commitment to advancing medical science. His innovative patent and collaborations highlight his significant role in addressing critical health challenges.